Article
Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design.
The Biochemical journal - 1 Oct 2016
Silkstone Gary G A, Silkstone Rebecca S, Wilson Michael T, Simons Michelle, Bülow Leif, Kallberg Kristian, Ratanasopa Khuanpiroon, Ronda Luca, Mozzarelli Andrea, Reeder Brandon J, Cooper Chris E
Abstract excerpt
Hemoglobin (Hb)-based oxygen carriers (HBOC) have been engineered to replace or augment the oxygen-carrying capacity of erythrocytes. However, clinical results have generally been disappointing due to adverse side effects linked to intrinsic heme-mediated oxidative toxicity and nitric oxide (NO) scavenging. Redox-active tyrosine residues can facilitate electron transfer between endogenous antioxidants and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
